Company Overview and News

0
Buru Energy accelerating exploration efforts following Roc Oil transactions

2018-05-22 proactiveinvestors.com.au
Buru Energy (ASX:BRU) executive chairman Eric Streitberg speaks to Proactive Investors about the Australia-focused oil and gas company's recent deal with Roc Oil (ASX:ROC) to sell half of its 100% ownership in the Ungani Oilfield for $64 million, and enter a Joint Venture on three of its most advanced exploration permits for a carry of $20 million. Buru Energy retains operatorship.
BRNGF BRU

0
Buru Energy to receive $84 million through sale and farm-in deal

2018-05-22 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) has entered into two transactions valued at $84 million with Roc Oil in relation to its Canning Basin oil production and exploration assets in Western Australia.
BRNGF BRU

0
Buru Energy to ramp up oil production from Ungani oilfield

2018-05-13 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) is producing from the Ungani 1 and Ungani 2 wells at a combined rate of up to 1,700 barrels of oil per day (bopd) on low pump rate settings as expected.
BRNGF BRU

0
Buru Energy has oil flowing again at Ungani project in Western Australia

2018-05-07 proactiveinvestors.com.au
Buru Energy Limited (ASX:BRU) has brought the Ungani 1 and 2 wells at the Ungani Oilfield Project in Western Australia back into production with strong results.
BRNGF BRU

0
Buru Energy set to restart oil production following access road reopening

2018-05-01 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) has sent 2,541 barrels of crude inventory to the storage tank at Wyndham after fully reopening the access road to its wholly-owned Ungani Oilfield in Western Australia.
BRNGF BRU

0
Buru Energy regains some access to Ungani Oil Field

2018-04-17 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) is able to use the Ungani access road with light vehicles as water levels have generally receded below the roadbed level.
BRNGF BRU

0
Report says WA fracking would blow Australia's whole carbon budget

2018-03-19 smh.com.au
Carbon pollution from fracking all Western Australia’s potential unconventional gas reserves would blow Australia’s entire carbon budget under the Paris Agreement three times over, new research shows.
BRNGF BRU

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:BRU / BURU ENERGY LIMITED on message board site Silicon Investor.

College Football: Nits, Gators, Bruins, Vols - Whoever! BRUSH CREEK MINING AND DEVELOPMENT (BCMD) NEWS
New Brunswick Scientific Co., Inc. (NBSC) Brush Engineered Materials
BDAL - Bruker Daltronics BBC - Bergen Brunswick Company
Watching Bruce Lee Brueggeru0027s Bagel Bakery bought by QDIN. Buy QDIN now?!!
Brunswick Technologies - BTIC Why is Bruce L such an annoying poster?